John B. Buse, MD, PhD - Exploring the Science and Practice of GLP-1 Receptor Agonists: An Update on Current and Emerging Evidence

Previous Episode: Vanita R. Aroda, MD - Putting Basal Insulin Therapy to Work for Patients With Type 2 Diabetes Mellitus

Next Episode: Sorayah Bourenane, MSN, RN, CNL / Marianne Davies, DNP, ACNP, AOCNP - Identification, Triage, and Management of Immune-Related Adverse Effects in Patients With Cancer Presenting to the Emergency Department: Practical Guidance for Emergency Nurses

Go online to PeerView.com/YYH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in endocrinology discusses the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in the treatment of patients with diabetes. Upon completion of this activity, participants should be better able to: Apply current guidelines for the use of GLP-1 RAs in appropriately selected patients with T2DM, Differentiate current and emerging GLP-1 RAs from each other and from other agents used to treat T2DM, Identify GLP-1 RAs indicated for CV risk reduction in patients with T2DM, Implement shared decision-making with patients with T2DM initiating GLP-1 RA therapy

John B. Buse, MD, PhD - Exploring the Science and Practice of GLP-1 Receptor Agonists: An Update on Current and Emerging Evidence

PeerView Endocrinology & Diabetes CME/CNE/CPE Audio Podcast